share_log

HC Wainwright & Co. Downgrades Co-Diagnostics to Neutral, Lowers Price Target to $3

Benzinga ·  Mar 20, 2023 07:51

HC Wainwright & Co. analyst Yi Chen downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Neutral and lowers the price target from $6 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment